BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 17314346)

  • 1. Synergistic copathogens--HIV-1 and HSV-2.
    Corey L
    N Engl J Med; 2007 Feb; 356(8):854-6. PubMed ID: 17314346
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression.
    Schacker T; Zeh J; Hu H; Shaughnessy M; Corey L
    J Infect Dis; 2002 Dec; 186(12):1718-25. PubMed ID: 12447756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HSV-2 suppression reduces HIV and HSV shedding.
    Collins S
    GMHC Treat Issues; 2005 Dec; 19(12):11. PubMed ID: 16909510
    [No Abstract]   [Full Text] [Related]  

  • 4. Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus.
    Nagot N; Ouédraogo A; Foulongne V; Konaté I; Weiss HA; Vergne L; Defer MC; Djagbaré D; Sanon A; Andonaba JB; Becquart P; Segondy M; Vallo R; Sawadogo A; Van de Perre P; Mayaud P;
    N Engl J Med; 2007 Feb; 356(8):790-9. PubMed ID: 17314338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpes simplex virus shedding and plasma human immunodeficiency virus RNA levels in coinfected women.
    Augenbraun M; Corey L; Reichelderfer P; Wright DJ; Burns D; Koelle DM; Robison E; Cohen M;
    Clin Infect Dis; 2001 Sep; 33(6):885-90. PubMed ID: 11512094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health care seeking among men with genital ulcer disease in South Africa: correlates and relationship to human immunodeficiency virus-1 and herpes simplex virus type 2 detection and shedding.
    Leichliter JS; Lewis DA; Sternberg M; Habel MA; Paz-Bailey G
    Sex Transm Dis; 2011 Sep; 38(9):865-70. PubMed ID: 21844743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomised placebo-controlled trial to explore the effect of suppressive therapy with acyclovir on genital shedding of HIV-1 and herpes simplex virus type 2 among Zimbabwean sex workers.
    Cowan FM; Pascoe SJ; Barlow KL; Langhaug LF; Jaffar S; Hargrove JW; Robinson NJ; Bassett MT; Wilson D; Brown DW; Hayes RJ
    Sex Transm Infect; 2008 Dec; 84(7):548-53. PubMed ID: 18684855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trial shows HSV-2 suppression can reduce HIV shedding.
    IAVI Rep; 2006; 10(1):20. PubMed ID: 16628770
    [No Abstract]   [Full Text] [Related]  

  • 9. Vitamin A supplementation and genital shedding of herpes simplex virus among HIV-1-infected women: a randomized clinical trial.
    Baeten JM; McClelland RS; Corey L; Overbaugh J; Lavreys L; Richardson BA; Wald A; Mandaliya K; Bwayo JJ; Kreiss JK
    J Infect Dis; 2004 Apr; 189(8):1466-71. PubMed ID: 15073684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An addition to the effect of treating co-infections on HIV-1 viral load.
    Modjarrad K; Vermund SH
    Lancet Infect Dis; 2011 Feb; 11(2):81. PubMed ID: 21272789
    [No Abstract]   [Full Text] [Related]  

  • 11. HIV-1 and herpes simplex virus type-2 genital shedding among co-infected women using self-collected swabs in Chiang Rai, Thailand.
    Forhan SE; Dunne EF; Sternberg MR; Whitehead SJ; Leelawiwat W; Thepamnuay S; Chen C; Evans-Strickfaden T; McNicholl JM; Markowitz LE
    Int J STD AIDS; 2012 Aug; 23(8):560-4. PubMed ID: 22930292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent developments in the management of herpes simplex virus infection in HIV-infected persons.
    Bartlett JG
    Clin Infect Dis; 2004 Nov; 39 Suppl 5():S237-9. PubMed ID: 15494894
    [No Abstract]   [Full Text] [Related]  

  • 13. Chronic herpes simplex virus type-2 infection and HIV viral load.
    Duffus WA; Mermin J; Bunnell R; Byers RH; Odongo G; Ekwaru P; Downing R
    Int J STD AIDS; 2005 Nov; 16(11):733-5. PubMed ID: 16303067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HSV-2 and HIV: consequences of an endemic opportunistic infection.
    Wald A; Schacker T; Corey L
    STEP Perspect; 1997; 9(3):2-4. PubMed ID: 11364936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating HIV infection with drugs for HSV-2 infection?
    Buvé A; Lynen L
    Lancet; 2010 Mar; 375(9717):782-4. PubMed ID: 20153889
    [No Abstract]   [Full Text] [Related]  

  • 16. Developments in STD/HIV interactions: the intertwining epidemics of HIV and HSV-2.
    Reynolds SJ; Quinn TC
    Infect Dis Clin North Am; 2005 Jun; 19(2):415-25. PubMed ID: 15963880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of genital herpes infections in HIV-infected patients.
    Foley E; Patel R
    J HIV Ther; 2004 Feb; 9(1):14-8. PubMed ID: 15071425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of HIV infection with drugs for HSV-2 infection.
    Huttner A; Calmy A
    Lancet; 2010 Jul; 376(9735):88; author reply 88. PubMed ID: 20621229
    [No Abstract]   [Full Text] [Related]  

  • 19. AIDS research. Promising prevention interventions perform poorly in trials.
    Cohen J
    Science; 2007 Jul; 317(5837):440. PubMed ID: 17656693
    [No Abstract]   [Full Text] [Related]  

  • 20. Self-collected genital swabs compared with cervicovaginal lavage for measuring HIV-1 and HSV-2 and the effect of acyclovir on viral shedding.
    McNicholl JM; Leelawiwat W; Whitehead S; Hanson DL; Evans-Strickfaden T; Cheng CY; Chonwattana W; Mueanpai F; Kittinunvorakoon C; Markowitz L; Dunne EF
    Int J STD AIDS; 2017 Mar; 28(4):372-379. PubMed ID: 27179350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.